VYNE Therapeutics Inc.

VYNE Therapeutics Inc.

VYNE
VYNE Therapeutics Inc.US flagNASDAQ Global Select
0.89
USD
+0.08
- -
14.88MMarket Cap

VYNE Therapeutics Inc. (VYNE) Stock Split History

Learn about VYNE Therapeutics Inc.'s most recent 1-for-18 basis stock split on February 13, 2023. Understand the impact on shareholders and the company's market position.

APIChatGPT

Latest Stock Split Details

Key information about VYNE Therapeutics Inc.'s most recent stock split

Split Date: 2023-02-13
Split Ratio: 1:18
Price Before Split: $0.21
Price After Split: $0.01

Developer API

Get VYNE split history as JSON

Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.

GETapi.roic.ai/v2/stock-splits/VYNE

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 18.00 times fewer shares (a 1:18 ratio)
  • The price per share is increased proportionally

Historical Stock Splits

A comprehensive history of VYNE Therapeutics Inc.'s stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2023-02-131:18Yes$0.21$0.01
2021-02-161:4Yes$2.53$0.63

About VYNE Therapeutics Inc.

Company overview and industry information

VYNE Therapeutics Inc. (VYNE) operates in the Biotechnology industry. The recent 1-for-18 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.

Biotechnology
Go to VYNE Therapeutics Inc. Summary

Last updated: 7/22/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.